10 Oversold Global Stocks To Buy Right Now
'There are decades where nothing happens, and there are weeks where decades happen" is apt when starting a piece about global stocks.
Silence Therapeutics Plc (SLN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 1,899,317 | $34,529,583 | -6% | 2.03% |
| 2. | Millennium Management Israel Englander | 1,110,230 | $20,183,981 | +42% | 0% |
| 3. | Vivo Capital Albert Cha And Frank Kung | 1,105,454 | $20,097,154 | 1.66% | |
| 4. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,000,000 | $18,180,000 | +7% | 0.08% |
| 5. | Deep Track Capital David Kroin | 1,000,000 | $18,180,000 | -27% | 0.57% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,612,877 | $62,755,673 | 3.63% | |
| 2. | 3,879,173 | $54,451,046 | 0.98% | |
| 3. | 2,104,875 | $36,561,679 | 4.05% | |
| 4. | 881,173 | $15,305,975 | 0.81% | |
| 5. | 177,834 | $3,144,105 | 0% |
News See All
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds
The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics, digital therapeutics...
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript
Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25.
Silence Therapeutics plc (NASDAQ:SLN) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Silence Therapeutics 2022 Annual Results Conference Call and Webcast. Please be advised that today's conference is being recorded.
8 Medical Stocks to Buy According to Mitchell Blutt's Consonance Capital
In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt's Consonance Capital.
Is Silence Therapeutics plc (SLN) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.